1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy

Technology appraisal guidance [TA301] Published: 27 November 2013

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

  • Stakeholder matrix PDF 261 KB 22 January 2018  
  • Review proposal paper PDF 299 KB 01 June 2018  

This page was last updated: 22 January 2018